1. Home
  2. PROF vs BNR Comparison

PROF vs BNR Comparison

Compare PROF & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.48

Market Cap

270.7M

Sector

Health Care

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$23.20

Market Cap

322.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
BNR
Founded
N/A
2014
Country
Canada
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.7M
322.1M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
PROF
BNR
Price
$7.48
$23.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
145.3K
10.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$10,680,000.00
N/A
Revenue This Year
$61.09
$136.32
Revenue Next Year
$120.94
N/A
P/E Ratio
$6.41
N/A
Revenue Growth
48.35
N/A
52 Week Low
$3.90
$2.18
52 Week High
$8.95
$41.72

Technical Indicators

Market Signals
Indicator
PROF
BNR
Relative Strength Index (RSI) 55.25 36.81
Support Level $5.31 $19.10
Resistance Level $7.95 $24.23
Average True Range (ATR) 0.42 1.77
MACD 0.10 -0.93
Stochastic Oscillator 75.38 5.24

Price Performance

Historical Comparison
PROF
BNR

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: